Walgreens Boots Alliance, Inc. remains a major player in the pharmaceutical distribution industry, with a strong emphasis on retail operations, which make up 87.2% of its net sales.
The company offers a wide range of products, including prescription and over-the-counter drugs, as well as beauty and cosmetic items.
As of August 2023, Walgreens operates 13,532 points of sale worldwide, with 8,706 locations in the United States, Puerto Rico, and the US Virgin Islands, in addition to its online sales platform.
Geographically, the United States accounts for 84% of the company's net sales, followed by Germany at 8.1% and the United Kingdom at 6.5%.
Wholesale distribution represents 8.1% of total sales, while the healthcare sector contributes the remaining 4.7%.
UBS has maintained its neutral rating on Walgreens Boots Alliance, reflecting the company's performance in a competitive market.